XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 118,307 $ 149,516 $ 381,659 $ 407,191
Cost of sales (101,014) (106,432) (284,185) (282,662)
Gross profit 17,293 43,084 97,474 124,529
Operating expenses        
Selling, general and administrative (26,365) (29,813) (86,885) (85,954)
Research, product development and regulatory (11,177) (9,080) (25,482) (27,363)
Transformation (8,139) 0 (16,636) 0
Operating (loss) income (28,388) 4,191 (31,529) 11,212
Change in fair value of equity investments 0 (247) 513 (324)
Interest expense, net (4,378) (3,384) (11,988) (8,282)
(Loss) income before provision for income taxes (32,766) 560 (43,004) 2,606
Income tax benefit (expense) 7,024 (885) 7,093 (2,066)
Net (loss) income $ (25,742) $ (325) $ (35,911) $ 540
Net (loss) income per common share-basic $ (0.91) $ (0.01) $ (1.28) $ 0.02
Net (loss) income per common share-assuming dilution $ (0.91) $ (0.01) $ (1.28) $ 0.02
Weighted average shares outstanding-basic 28,173 27,919 28,015 28,236
Weighted average shares outstanding-assuming dilution 28,173 27,919 28,015 28,656